Bio Rad Laboratories Inc BIO.B:NYSE

RT Quote | NYSE | USD
Last | 02/24/21 EST
600.70UNCH (UNCH)
Volume
50
52 week range
324.07 - 668.56

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close600.70
  • 52 Week High668.56
  • 52 Week High Date02/12/21
  • 52 Week Low324.07
  • 52 Week Low Date03/12/20
  • Market Cap17.925B
  • Shares Out29.84M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.83
  • 1 Year % Change71.63

RATIOS/PROFITABILITY

  • EPS (TTM)126.20
  • P/E (TTM)4.76
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)561.557M
  • ROE (MRQ)48.69%
  • Revenue (MRQ)2.546B
  • Gross Margin (MRQ)56.54%
  • Net Margin (MRQ)149.52%
  • Debt To Equity (MRQ)0.14%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bio Rad Laboratories Inc News

There is no recent news for this security.

Latest BIO.B News From Our Partners

QUOTE FINDER

Profile

MORE
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory...
Norman Schwartz
Chairman
Andrew Last Ph.D.
Chief Operating Officer
Ilan Daskal
Chief Financial Officer
Timothy Ernst
Executive Vice President
Dara Wright
Executive Vice President
Ronald Hutton
Vice President
Address
1000 ALFRED NOBEL DR
Hercules, CA
94547-1811
United States